Click HERE To Grab Your Free Copy of "The Clean Eating Pantry Report"!
Glucagon-like peptide-1 (GLP-1) is a hormone that plays a crucial role in managing glucose levels in the body. It is secreted by the cells in the intestine and brain in response to food intake. This hormone has been of significant interest to researchers and healthcare professionals due to its potential therapeutic benefits for type 2 diabetes and obesity. Both prescription and natural forms of GLP-1 exist, each with distinct mechanisms of action.
Prescription forms of GLP-1, also known as GLP-1 receptor agonists, are synthetic versions designed to mimic the functions of natural GLP-1. They are typically administered through injections and have been engineered to remain active in the body for longer periods than their natural counterpart. These drugs work by binding to GLP-1 receptors on pancreatic beta cells, stimulating insulin production while suppressing glucagon secretion. This dual action effectively reduces blood glucose levels.
In addition to regulating glucose homeostasis, prescription GLP-1 receptor agonists also slow gastric emptying, which contributes to a feeling of fullness after meals and can aid weight loss. Furthermore, they have been shown to protect beta cells from apoptosis (cell death), potentially preserving their function over time.
On the other hand, natural forms of GLP-1 are produced within the body in response to nutrient intake. The primary mechanism through which natural GLP-1 operates is by stimulating insulin secretion from pancreatic beta cells in a glucose-dependent manner. This means that when blood glucose levels are high, more insulin is released; when they’re low, less insulin is produced.
Similar to its synthetic counterparts, natural GLP-1 also suppresses glucagon secretion from alpha cells in the pancreas when glucose levels are high but not when they’re low. This fine-tunes blood sugar regulation by preventing excessive glucose production by the liver.
However, unlike prescription forms of GLP-1 that have been engineered for longer-lasting effects, natural GLP-1 is rapidly degraded by an enzyme called dipeptidyl peptidase-4 (DPP-4). This limits the duration of its action to just a few minutes.
Despite their differences, both prescription and natural forms of GLP-1 share the common goal of maintaining glucose homeostasis. However, the synthetic versions offer additional benefits such as prolonged activity and weight loss support. As our understanding of GLP-1 continues to evolve, it’s likely that new therapeutic strategies will emerge that harness the power of this remarkable hormone in even more effective ways.